Author： Ronaldson Kathlyn J.
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.29, Iss.11, 2006-01, pp. : 1061-1067
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Risk factors for Rhabdomyolysis with Simvastatin and Atorvastatin
By Golomb Beatrice Evans Marcella
Drug Safety, Vol. 29, Iss. 12, 2006-01 ,pp. :
Access to resources
Recommend
Atorvastatin/clarithromycin/simvastatin: Rhabdomyolysis and neuropathy: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1311, 2010-01 ,pp. :
Atorvastatin/simvastatin/fusidic acid interaction: Rhabdomyolysis: 4 case reports
Reactions Weekly, Vol. 1, Iss. 1311, 2010-01 ,pp. :
Atorvastatin/fusidic acid/simvastatin interaction: Rhabdomyolysis: 4 case reports
Reactions Weekly, Vol. 1, Iss. 1336, 2011-01 ,pp. :
Risk Management of Simvastatin or Atorvastatin Interactions with CYP3A4 Inhibitors
By Molden Espen
Drug Safety, Vol. 31, Iss. 7, 2008-01 ,pp. :